Cargando…
Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future
Drug-induced cardiotoxicity (DICT) is an important concern of drug safety in both drug development and clinical application. The clinical manifestations of DICT include cardiomyopathy, arrhythmia, myocardial ischemia, heart failure, and a series of cardiac structural and functional changes. The occu...
Autores principales: | Li, Mo-Yun, Peng, Li-Ming, Chen, Xiao-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606405/ https://www.ncbi.nlm.nih.gov/pubmed/36312261 http://dx.doi.org/10.3389/fcvm.2022.966261 |
Ejemplares similares
-
Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies
por: Sangweni, Nonhlakanipho F., et al.
Publicado: (2022) -
Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity
por: Chen, De-Shu, et al.
Publicado: (2022) -
Risk Factors for Anthracycline-Induced Cardiotoxicity
por: Qiu, Shuo, et al.
Publicado: (2021) -
microRNA-377 Signaling Modulates Anticancer Drug-Induced Cardiotoxicity in Mice
por: Henderson, John, et al.
Publicado: (2021) -
Novel Therapeutics for Anthracycline Induced Cardiotoxicity
por: Vuong, Jacqueline T., et al.
Publicado: (2022)